Stocks and Investing Stocks and Investing
Fri, April 17, 2020
[ 12:00 AM ] - WOPRAI
Ariel Rosa Maintained (XPO) at Strong Buy with Decreased Target to $74 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Patrick Brown Maintained (XPO) at Buy with Decreased Target to $75 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Brandon Oglenski Maintained (XPO) at Hold with Decreased Target to $65 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Jim Duffy Downgraded (YETI) to Hold and Held Target at $23 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
John White Upgraded (WTI) to Strong Buy and Held Target at $3.8 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Michael Gambardella Maintained (X) at Hold with Decreased Target to $6 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (BX) at Buy with Decreased Target to $62 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Lucas Pipes Maintained (BTU) at Hold and Held Target at $5 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Melissa Franchi Maintained (BOX) at Buy with Increased Target to $17 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Kenneth Goldman Maintained (BRBR) at Buy with Decreased Target to $24 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Timothy Horan Maintained (AKAM) at Buy with Increased Target to $130 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Mark Mahaney Downgraded (CARG) to Hold and Decreased Target to $22 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Greg Peters Maintained (CB) at Buy with Decreased Target to $160 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Tuna Amobi Maintained (CAKE) at Hold with Decreased Target to $20 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Aaron Kessler Maintained (BABA) at Strong Buy with Decreased Target to $290 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Myles Walton Maintained (B) at Strong Buy with Decreased Target to $50 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Michael Gambardella Maintained (AA) at Buy with Decreased Target to $14 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Jason Helfstein Maintained (BIDU) at Buy with Decreased Target to $155 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Ken Cacciatore Initiated (BHVN) at Buy and Held Target at $45 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Gabe Hajde Maintained (BERY) at Buy with Decreased Target to $52 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Vijay Rakesh Maintained (ALV) at Strong Buy with Decreased Target to $75 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Rod Hall Upgraded (ADTN) to Strong Buy and Held Target at $13 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Charles Peters Downgraded (AFG) to Sell on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Charles Peters Maintained (AFL) at Buy with Decreased Target to $50 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Blayne Curtis Maintained (ADI) at Buy with Decreased Target to $115 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (APO) at Hold with Decreased Target to $39 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Lucas Pipes Maintained (ARLP) at Hold with Increased Target to $7 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (ARES) at Hold with Decreased Target to $33 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Lucas Pipes Maintained (ARCH) at Strong Buy with Decreased Target to $79 on, Apr 17th, 2020
[ 12:00 AM ] - WOPRAI
Leland Gershell Maintained (URGN) at Buy with Increased Target to $47 on, Apr 17th, 2020

Leland Gershell Maintained (URGN) at Buy with Increased Target to $47 on, Apr 17th, 2020


Published on 2024-10-27 03:18:03 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "UroGen Pharma Ltd." (URGN) at Buy with Increased Target from $45 to $47 on, Apr 17th, 2020.

Leland has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Leland's Rating of Hold.



This is the rating of the analyst that currently disagrees with Leland

  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $57 on, Thursday, April 16th, 2020
Contributing Sources